SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001193125-23-179647
Filing Date
2023-06-30
Accepted
2023-06-30 09:16:07
Documents
7
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 PREM14A d468238dprem14a.htm PREM14A 2154025
2 EX-FILING FEES d468238dexfilingfees.htm EX-FILING FEES 19285
3 GRAPHIC g468238dsp118.jpg GRAPHIC 184455
4 GRAPHIC g468238dsp119.jpg GRAPHIC 171747
5 GRAPHIC g468238g10w10.jpg GRAPHIC 24090
6 GRAPHIC g468238g11w11.jpg GRAPHIC 21929
7 GRAPHIC g468238g38p02.jpg GRAPHIC 28471
  Complete submission text file 0001193125-23-179647.txt   2768322
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-36066 | Film No.: 231059770
SIC: 2834 Pharmaceutical Preparations